Article info

Download PDFPDF

Hepatocellular carcinomas: evolution to sorafenib resistance through hepatic leukaemia factor

Authors

  1. Correspondence to Dr Orlando Musso, INSERM UMR991, Universite de Rennes, INRA Institut NUMECAN (Nutrition Metabolisms and Cancer), F-35033 Rennes, France; orlando.musso{at}inserm.fr
View Full Text

Citation

Musso O, Beraza N
Hepatocellular carcinomas: evolution to sorafenib resistance through hepatic leukaemia factor

Publication history

  • Received June 10, 2019
  • Accepted June 12, 2019
  • First published July 3, 2019.
Online issue publication 
September 06, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.